Agilent Technologies (NYSE:A) issued its quarterly earnings data on Wednesday. The medical research company reported $0.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.08, Bloomberg Earnings reports. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.16 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. During the same period last year, the company earned $0.53 EPS. Agilent Technologies updated its Q2 guidance to $0.61-0.63 EPS and its FY18 guidance to $2.62-2.68 EPS.
Agilent Technologies (NYSE A) traded up $1.98 during trading on Thursday, reaching $71.68. The company’s stock had a trading volume of 1,057,134 shares, compared to its average volume of 2,190,426. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. Agilent Technologies has a twelve month low of $50.56 and a twelve month high of $75.00. The company has a market capitalization of $22,054.50, a P/E ratio of 33.19, a price-to-earnings-growth ratio of 2.06 and a beta of 1.28.
A has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a research report on Tuesday, October 31st. Robert W. Baird restated a “buy” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Friday, October 20th. Cowen restated a “hold” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Deutsche Bank set a $75.00 price target on Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. Finally, JPMorgan Chase & Co. lifted their price target on Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Agilent Technologies presently has an average rating of “Buy” and an average price target of $69.25.
TRADEMARK VIOLATION WARNING: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/02/15/agilent-technologies-a-posts-earnings-results-beats-expectations-by-0-08-eps.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.